nodes	percent_of_prediction	percent_of_DWPC	metapath
Maprotiline—panic disorder—Diazepam—epilepsy syndrome	0.168	0.623	CpDpCtD
Maprotiline—panic disorder—Clonazepam—epilepsy syndrome	0.102	0.377	CpDpCtD
Maprotiline—CHRM3—epilepsy syndrome	0.0552	0.226	CbGaD
Maprotiline—CHRM1—epilepsy syndrome	0.0515	0.211	CbGaD
Maprotiline—Protriptyline—Carbamazepine—epilepsy syndrome	0.0425	0.197	CrCrCtD
Maprotiline—CHRM2—epilepsy syndrome	0.0421	0.172	CbGaD
Maprotiline—HTR7—epilepsy syndrome	0.0418	0.171	CbGaD
Maprotiline—Indecainide—Oxcarbazepine—epilepsy syndrome	0.0369	0.171	CrCrCtD
Maprotiline—Nortriptyline—Oxcarbazepine—epilepsy syndrome	0.0257	0.119	CrCrCtD
Maprotiline—Desipramine—Carbamazepine—epilepsy syndrome	0.0218	0.101	CrCrCtD
Maprotiline—HTR2A—epilepsy syndrome	0.021	0.086	CbGaD
Maprotiline—Desipramine—Oxcarbazepine—epilepsy syndrome	0.0201	0.0928	CrCrCtD
Maprotiline—CYP2D6—epilepsy syndrome	0.0192	0.0787	CbGaD
Maprotiline—Dimetacrine—Carbamazepine—epilepsy syndrome	0.0184	0.0852	CrCrCtD
Maprotiline—Imipramine—Carbamazepine—epilepsy syndrome	0.0177	0.0816	CrCrCtD
Maprotiline—Dimetacrine—Oxcarbazepine—epilepsy syndrome	0.017	0.0785	CrCrCtD
Maprotiline—Imipramine—Oxcarbazepine—epilepsy syndrome	0.0163	0.0752	CrCrCtD
Maprotiline—ABCB1—epilepsy syndrome	0.0137	0.0562	CbGaD
Maprotiline—ABCB1—Levetiracetam—epilepsy syndrome	0.0109	0.118	CbGbCtD
Maprotiline—ABCB1—Clobazam—epilepsy syndrome	0.00755	0.0817	CbGbCtD
Maprotiline—ABCB1—Lamotrigine—epilepsy syndrome	0.00727	0.0786	CbGbCtD
Maprotiline—CYP1A2—Carbamazepine—epilepsy syndrome	0.00716	0.0774	CbGbCtD
Maprotiline—CYP1A2—Primidone—epilepsy syndrome	0.00668	0.0723	CbGbCtD
Maprotiline—ABCB1—Carbamazepine—epilepsy syndrome	0.00626	0.0677	CbGbCtD
Maprotiline—CYP1A2—Propofol—epilepsy syndrome	0.00599	0.0648	CbGbCtD
Maprotiline—CYP1A2—Phenobarbital—epilepsy syndrome	0.00572	0.0619	CbGbCtD
Maprotiline—ABCB1—Phenytoin—epilepsy syndrome	0.00561	0.0607	CbGbCtD
Maprotiline—CYP1A2—Diazepam—epilepsy syndrome	0.00542	0.0587	CbGbCtD
Maprotiline—ABCB1—Phenobarbital—epilepsy syndrome	0.005	0.0541	CbGbCtD
Maprotiline—ABCB1—Midazolam—epilepsy syndrome	0.00493	0.0534	CbGbCtD
Maprotiline—CYP2D6—Propofol—epilepsy syndrome	0.00493	0.0534	CbGbCtD
Maprotiline—ABCB1—Diazepam—epilepsy syndrome	0.00474	0.0513	CbGbCtD
Maprotiline—CYP1A2—Valproic Acid—epilepsy syndrome	0.00428	0.0462	CbGbCtD
Maprotiline—HTR2A—phrenic nerve—epilepsy syndrome	0.00189	0.0614	CbGeAlD
Maprotiline—SLC6A2—locus ceruleus—epilepsy syndrome	0.0014	0.0457	CbGeAlD
Maprotiline—HTR7—locus ceruleus—epilepsy syndrome	0.00135	0.044	CbGeAlD
Maprotiline—HTR7—vagus nerve—epilepsy syndrome	0.00104	0.0337	CbGeAlD
Maprotiline—HTR2A—locus ceruleus—epilepsy syndrome	0.000844	0.0274	CbGeAlD
Maprotiline—SLC6A3—telencephalic ventricle—epilepsy syndrome	0.000825	0.0268	CbGeAlD
Maprotiline—HTR2C—telencephalic ventricle—epilepsy syndrome	0.000798	0.0259	CbGeAlD
Maprotiline—HTR7—pons—epilepsy syndrome	0.00078	0.0254	CbGeAlD
Maprotiline—SLC6A2—autonomic nervous system—epilepsy syndrome	0.000746	0.0243	CbGeAlD
Maprotiline—HTR7—autonomic nervous system—epilepsy syndrome	0.000719	0.0234	CbGeAlD
Maprotiline—HTR2A—cerebellar cortex—epilepsy syndrome	0.000688	0.0224	CbGeAlD
Maprotiline—HTR2A—vagus nerve—epilepsy syndrome	0.000646	0.021	CbGeAlD
Maprotiline—HTR7—telencephalic ventricle—epilepsy syndrome	0.000642	0.0209	CbGeAlD
Maprotiline—DRD2—telencephalic ventricle—epilepsy syndrome	0.000607	0.0197	CbGeAlD
Maprotiline—SLC6A3—ganglion—epilepsy syndrome	0.000514	0.0167	CbGeAlD
Maprotiline—HTR2C—ganglion—epilepsy syndrome	0.000497	0.0162	CbGeAlD
Maprotiline—HTR2A—pons—epilepsy syndrome	0.000486	0.0158	CbGeAlD
Maprotiline—HTR2A—autonomic nervous system—epilepsy syndrome	0.000449	0.0146	CbGeAlD
Maprotiline—SLC6A2—ganglion—epilepsy syndrome	0.000415	0.0135	CbGeAlD
Maprotiline—HTR2A—telencephalic ventricle—epilepsy syndrome	0.0004	0.013	CbGeAlD
Maprotiline—HTR7—ganglion—epilepsy syndrome	0.0004	0.013	CbGeAlD
Maprotiline—SLC6A3—hindbrain—epilepsy syndrome	0.00039	0.0127	CbGeAlD
Maprotiline—DRD2—ganglion—epilepsy syndrome	0.000378	0.0123	CbGeAlD
Maprotiline—HTR7—hindbrain—epilepsy syndrome	0.000303	0.00985	CbGeAlD
Maprotiline—DRD2—hindbrain—epilepsy syndrome	0.000286	0.00932	CbGeAlD
Maprotiline—HTR2A—ganglion—epilepsy syndrome	0.000249	0.0081	CbGeAlD
Maprotiline—CHRM4—head—epilepsy syndrome	0.000231	0.0075	CbGeAlD
Maprotiline—SLC6A3—brainstem—epilepsy syndrome	0.000223	0.00726	CbGeAlD
Maprotiline—CHRM4—nervous system—epilepsy syndrome	0.000219	0.00711	CbGeAlD
Maprotiline—CHRM2—forebrain—epilepsy syndrome	0.000216	0.00703	CbGeAlD
Maprotiline—HTR2C—brainstem—epilepsy syndrome	0.000216	0.00702	CbGeAlD
Maprotiline—SLC6A3—forebrain—epilepsy syndrome	0.000216	0.00701	CbGeAlD
Maprotiline—CHRM4—central nervous system—epilepsy syndrome	0.000211	0.00685	CbGeAlD
Maprotiline—HTR2C—forebrain—epilepsy syndrome	0.000208	0.00678	CbGeAlD
Maprotiline—CHRM2—telencephalon—epilepsy syndrome	0.000199	0.00646	CbGeAlD
Maprotiline—SLC6A3—telencephalon—epilepsy syndrome	0.000198	0.00645	CbGeAlD
Maprotiline—CHRM1—forebrain—epilepsy syndrome	0.000197	0.0064	CbGeAlD
Maprotiline—HTR2C—telencephalon—epilepsy syndrome	0.000192	0.00623	CbGeAlD
Maprotiline—HTR2A—hindbrain—epilepsy syndrome	0.000189	0.00614	CbGeAlD
Maprotiline—CHRM1—telencephalon—epilepsy syndrome	0.000181	0.00588	CbGeAlD
Maprotiline—CHRM5—head—epilepsy syndrome	0.00018	0.00586	CbGeAlD
Maprotiline—SLC6A2—brainstem—epilepsy syndrome	0.00018	0.00586	CbGeAlD
Maprotiline—CHRM3—forebrain—epilepsy syndrome	0.000176	0.00573	CbGeAlD
Maprotiline—SLC6A2—forebrain—epilepsy syndrome	0.000174	0.00565	CbGeAlD
Maprotiline—HTR7—brainstem—epilepsy syndrome	0.000174	0.00565	CbGeAlD
Maprotiline—CYP2D6—hindbrain—epilepsy syndrome	0.000172	0.0056	CbGeAlD
Maprotiline—CHRM5—nervous system—epilepsy syndrome	0.000171	0.00556	CbGeAlD
Maprotiline—HTR7—forebrain—epilepsy syndrome	0.000168	0.00545	CbGeAlD
Maprotiline—CHRM4—brain—epilepsy syndrome	0.000167	0.00544	CbGeAlD
Maprotiline—CHRM5—central nervous system—epilepsy syndrome	0.000165	0.00535	CbGeAlD
Maprotiline—DRD2—brainstem—epilepsy syndrome	0.000164	0.00534	CbGeAlD
Maprotiline—CHRM3—telencephalon—epilepsy syndrome	0.000162	0.00527	CbGeAlD
Maprotiline—SLC6A2—telencephalon—epilepsy syndrome	0.00016	0.0052	CbGeAlD
Maprotiline—DRD2—forebrain—epilepsy syndrome	0.000158	0.00515	CbGeAlD
Maprotiline—HTR7—telencephalon—epilepsy syndrome	0.000154	0.00501	CbGeAlD
Maprotiline—Imipramine—KCND2—epilepsy syndrome	0.000154	0.0795	CrCbGaD
Maprotiline—HTR2C—medulla oblongata—epilepsy syndrome	0.000151	0.0049	CbGeAlD
Maprotiline—ORM1—spinal cord—epilepsy syndrome	0.000149	0.00486	CbGeAlD
Maprotiline—DRD2—telencephalon—epilepsy syndrome	0.000146	0.00474	CbGeAlD
Maprotiline—SLC6A3—midbrain—epilepsy syndrome	0.000142	0.00463	CbGeAlD
Maprotiline—SLC6A3—spinal cord—epilepsy syndrome	0.000139	0.00452	CbGeAlD
Maprotiline—HTR2C—midbrain—epilepsy syndrome	0.000138	0.00447	CbGeAlD
Maprotiline—Sertraline—SLC6A4—epilepsy syndrome	0.000136	0.0706	CrCbGaD
Maprotiline—HTR2C—spinal cord—epilepsy syndrome	0.000134	0.00437	CbGeAlD
Maprotiline—CHRM5—brain—epilepsy syndrome	0.000131	0.00425	CbGeAlD
Maprotiline—Sertraline—CYP2C19—epilepsy syndrome	0.000129	0.0669	CrCbGaD
Maprotiline—ORM1—nervous system—epilepsy syndrome	0.000126	0.00409	CbGeAlD
Maprotiline—SLC6A2—medulla oblongata—epilepsy syndrome	0.000126	0.00409	CbGeAlD
Maprotiline—HRH1—forebrain—epilepsy syndrome	0.000125	0.00407	CbGeAlD
Maprotiline—CHRM2—head—epilepsy syndrome	0.000124	0.00403	CbGeAlD
Maprotiline—SLC6A3—head—epilepsy syndrome	0.000123	0.00401	CbGeAlD
Maprotiline—ORM1—central nervous system—epilepsy syndrome	0.000121	0.00394	CbGeAlD
Maprotiline—HTR7—medulla oblongata—epilepsy syndrome	0.000121	0.00394	CbGeAlD
Maprotiline—HTR2C—head—epilepsy syndrome	0.000119	0.00388	CbGeAlD
Maprotiline—Metixene—CHRM3—epilepsy syndrome	0.000118	0.061	CrCbGaD
Maprotiline—CHRM2—nervous system—epilepsy syndrome	0.000117	0.00382	CbGeAlD
Maprotiline—SLC6A3—nervous system—epilepsy syndrome	0.000117	0.00381	CbGeAlD
Maprotiline—HRH1—telencephalon—epilepsy syndrome	0.000115	0.00374	CbGeAlD
Maprotiline—HTR2C—nervous system—epilepsy syndrome	0.000113	0.00368	CbGeAlD
Maprotiline—CHRM2—central nervous system—epilepsy syndrome	0.000113	0.00367	CbGeAlD
Maprotiline—CHRM1—head—epilepsy syndrome	0.000113	0.00366	CbGeAlD
Maprotiline—SLC6A3—central nervous system—epilepsy syndrome	0.000113	0.00366	CbGeAlD
Maprotiline—HTR7—midbrain—epilepsy syndrome	0.000111	0.0036	CbGeAlD
Maprotiline—SLC6A3—cerebellum—epilepsy syndrome	0.00011	0.00358	CbGeAlD
Maprotiline—Metixene—CHRM1—epilepsy syndrome	0.00011	0.0569	CrCbGaD
Maprotiline—HTR2C—central nervous system—epilepsy syndrome	0.000109	0.00354	CbGeAlD
Maprotiline—HTR2A—brainstem—epilepsy syndrome	0.000108	0.00352	CbGeAlD
Maprotiline—HTR7—spinal cord—epilepsy syndrome	0.000108	0.00351	CbGeAlD
Maprotiline—CHRM1—nervous system—epilepsy syndrome	0.000107	0.00347	CbGeAlD
Maprotiline—DRD2—midbrain—epilepsy syndrome	0.000105	0.0034	CbGeAlD
Maprotiline—HTR2A—forebrain—epilepsy syndrome	0.000105	0.0034	CbGeAlD
Maprotiline—CHRM1—central nervous system—epilepsy syndrome	0.000103	0.00334	CbGeAlD
Maprotiline—CHRM3—head—epilepsy syndrome	0.000101	0.00328	CbGeAlD
Maprotiline—SLC6A2—head—epilepsy syndrome	9.96e-05	0.00324	CbGeAlD
Maprotiline—CYP2D6—brainstem—epilepsy syndrome	9.87e-05	0.00321	CbGeAlD
Maprotiline—HTR2A—telencephalon—epilepsy syndrome	9.61e-05	0.00313	CbGeAlD
Maprotiline—HTR7—head—epilepsy syndrome	9.6e-05	0.00312	CbGeAlD
Maprotiline—Sertraline—CYP2D6—epilepsy syndrome	9.59e-05	0.0496	CrCbGaD
Maprotiline—CHRM3—nervous system—epilepsy syndrome	9.56e-05	0.00311	CbGeAlD
Maprotiline—CYP2D6—forebrain—epilepsy syndrome	9.52e-05	0.0031	CbGeAlD
Maprotiline—SLC6A2—nervous system—epilepsy syndrome	9.44e-05	0.00307	CbGeAlD
Maprotiline—CHRM3—central nervous system—epilepsy syndrome	9.2e-05	0.00299	CbGeAlD
Maprotiline—HTR7—nervous system—epilepsy syndrome	9.1e-05	0.00296	CbGeAlD
Maprotiline—SLC6A2—central nervous system—epilepsy syndrome	9.09e-05	0.00296	CbGeAlD
Maprotiline—DRD2—head—epilepsy syndrome	9.07e-05	0.00295	CbGeAlD
Maprotiline—Metixene—CHRM2—epilepsy syndrome	8.99e-05	0.0465	CrCbGaD
Maprotiline—CHRM2—brain—epilepsy syndrome	8.97e-05	0.00292	CbGeAlD
Maprotiline—SLC6A3—brain—epilepsy syndrome	8.94e-05	0.00291	CbGeAlD
Maprotiline—HTR7—central nervous system—epilepsy syndrome	8.76e-05	0.00285	CbGeAlD
Maprotiline—CYP2D6—telencephalon—epilepsy syndrome	8.76e-05	0.00285	CbGeAlD
Maprotiline—HTR2C—brain—epilepsy syndrome	8.65e-05	0.00281	CbGeAlD
Maprotiline—DRD2—nervous system—epilepsy syndrome	8.6e-05	0.0028	CbGeAlD
Maprotiline—HTR7—cerebellum—epilepsy syndrome	8.56e-05	0.00278	CbGeAlD
Maprotiline—DRD2—central nervous system—epilepsy syndrome	8.28e-05	0.00269	CbGeAlD
Maprotiline—CHRM1—brain—epilepsy syndrome	8.17e-05	0.00266	CbGeAlD
Maprotiline—DRD2—cerebellum—epilepsy syndrome	8.1e-05	0.00263	CbGeAlD
Maprotiline—Protriptyline—SLC6A4—epilepsy syndrome	7.84e-05	0.0405	CrCbGaD
Maprotiline—HTR2A—medulla oblongata—epilepsy syndrome	7.55e-05	0.00246	CbGeAlD
Maprotiline—CHRM3—brain—epilepsy syndrome	7.31e-05	0.00238	CbGeAlD
Maprotiline—SLC6A2—brain—epilepsy syndrome	7.22e-05	0.00235	CbGeAlD
Maprotiline—HRH1—head—epilepsy syndrome	7.17e-05	0.00233	CbGeAlD
Maprotiline—HTR7—brain—epilepsy syndrome	6.96e-05	0.00226	CbGeAlD
Maprotiline—HTR2A—midbrain—epilepsy syndrome	6.9e-05	0.00224	CbGeAlD
Maprotiline—ABCB1—forebrain—epilepsy syndrome	6.85e-05	0.00223	CbGeAlD
Maprotiline—Sertraline—ABCB1—epilepsy syndrome	6.85e-05	0.0354	CrCbGaD
Maprotiline—HRH1—nervous system—epilepsy syndrome	6.79e-05	0.00221	CbGeAlD
Maprotiline—HTR2A—spinal cord—epilepsy syndrome	6.73e-05	0.00219	CbGeAlD
Maprotiline—DRD2—brain—epilepsy syndrome	6.58e-05	0.00214	CbGeAlD
Maprotiline—HRH1—central nervous system—epilepsy syndrome	6.54e-05	0.00213	CbGeAlD
Maprotiline—ABCB1—telencephalon—epilepsy syndrome	6.3e-05	0.00205	CbGeAlD
Maprotiline—Nortriptyline—CHRM3—epilepsy syndrome	6.06e-05	0.0313	CrCbGaD
Maprotiline—HTR2A—head—epilepsy syndrome	5.99e-05	0.00195	CbGeAlD
Maprotiline—HTR2A—nervous system—epilepsy syndrome	5.67e-05	0.00185	CbGeAlD
Maprotiline—Nortriptyline—CHRM1—epilepsy syndrome	5.65e-05	0.0292	CrCbGaD
Maprotiline—Protriptyline—CYP2D6—epilepsy syndrome	5.51e-05	0.0285	CrCbGaD
Maprotiline—HTR2A—central nervous system—epilepsy syndrome	5.46e-05	0.00178	CbGeAlD
Maprotiline—CYP2D6—head—epilepsy syndrome	5.45e-05	0.00177	CbGeAlD
Maprotiline—HTR2A—cerebellum—epilepsy syndrome	5.34e-05	0.00174	CbGeAlD
Maprotiline—HRH1—brain—epilepsy syndrome	5.19e-05	0.00169	CbGeAlD
Maprotiline—CYP2D6—nervous system—epilepsy syndrome	5.17e-05	0.00168	CbGeAlD
Maprotiline—Desipramine—CHRM3—epilepsy syndrome	4.99e-05	0.0258	CrCbGaD
Maprotiline—CYP2D6—central nervous system—epilepsy syndrome	4.98e-05	0.00162	CbGeAlD
Maprotiline—ABCB1—medulla oblongata—epilepsy syndrome	4.95e-05	0.00161	CbGeAlD
Maprotiline—CYP2D6—cerebellum—epilepsy syndrome	4.86e-05	0.00158	CbGeAlD
Maprotiline—Desipramine—CHRM1—epilepsy syndrome	4.65e-05	0.0241	CrCbGaD
Maprotiline—Nortriptyline—CHRM2—epilepsy syndrome	4.61e-05	0.0239	CrCbGaD
Maprotiline—ABCB1—midbrain—epilepsy syndrome	4.52e-05	0.00147	CbGeAlD
Maprotiline—ABCB1—spinal cord—epilepsy syndrome	4.41e-05	0.00143	CbGeAlD
Maprotiline—HTR2A—brain—epilepsy syndrome	4.34e-05	0.00141	CbGeAlD
Maprotiline—Imipramine—CHRM3—epilepsy syndrome	4.23e-05	0.0219	CrCbGaD
Maprotiline—CYP2D6—brain—epilepsy syndrome	3.95e-05	0.00128	CbGeAlD
Maprotiline—Imipramine—CHRM1—epilepsy syndrome	3.95e-05	0.0204	CrCbGaD
Maprotiline—Protriptyline—ABCB1—epilepsy syndrome	3.93e-05	0.0203	CrCbGaD
Maprotiline—ABCB1—head—epilepsy syndrome	3.92e-05	0.00128	CbGeAlD
Maprotiline—Desipramine—CHRM2—epilepsy syndrome	3.8e-05	0.0196	CrCbGaD
Maprotiline—ABCB1—nervous system—epilepsy syndrome	3.72e-05	0.00121	CbGeAlD
Maprotiline—ABCB1—central nervous system—epilepsy syndrome	3.58e-05	0.00116	CbGeAlD
Maprotiline—ABCB1—cerebellum—epilepsy syndrome	3.5e-05	0.00114	CbGeAlD
Maprotiline—Atomoxetine—SLC6A4—epilepsy syndrome	3.44e-05	0.0178	CrCbGaD
Maprotiline—Atomoxetine—CYP2C19—epilepsy syndrome	3.26e-05	0.0169	CrCbGaD
Maprotiline—Imipramine—CHRM2—epilepsy syndrome	3.22e-05	0.0167	CrCbGaD
Maprotiline—Imipramine—HTR7—epilepsy syndrome	3.21e-05	0.0166	CrCbGaD
Maprotiline—Nortriptyline—SLC6A4—epilepsy syndrome	3e-05	0.0155	CrCbGaD
Maprotiline—Nortriptyline—CYP2C19—epilepsy syndrome	2.85e-05	0.0147	CrCbGaD
Maprotiline—ABCB1—brain—epilepsy syndrome	2.84e-05	0.000924	CbGeAlD
Maprotiline—Atomoxetine—HTR2A—epilepsy syndrome	2.64e-05	0.0137	CrCbGaD
Maprotiline—Desipramine—SLC6A4—epilepsy syndrome	2.47e-05	0.0128	CrCbGaD
Maprotiline—Atomoxetine—CYP2D6—epilepsy syndrome	2.42e-05	0.0125	CrCbGaD
Maprotiline—Desipramine—CYP2C19—epilepsy syndrome	2.34e-05	0.0121	CrCbGaD
Maprotiline—Nortriptyline—HTR2A—epilepsy syndrome	2.31e-05	0.0119	CrCbGaD
Maprotiline—Diarrhoea—Felbamate—epilepsy syndrome	2.29e-05	0.000247	CcSEcCtD
Maprotiline—Abdominal pain—Lamotrigine—epilepsy syndrome	2.28e-05	0.000247	CcSEcCtD
Maprotiline—Body temperature increased—Lamotrigine—epilepsy syndrome	2.28e-05	0.000247	CcSEcCtD
Maprotiline—Dysgeusia—Gabapentin—epilepsy syndrome	2.28e-05	0.000247	CcSEcCtD
Maprotiline—Dizziness—Diazepam—epilepsy syndrome	2.28e-05	0.000247	CcSEcCtD
Maprotiline—Infection—Valproic Acid—epilepsy syndrome	2.28e-05	0.000246	CcSEcCtD
Maprotiline—Syncope—Pregabalin—epilepsy syndrome	2.28e-05	0.000246	CcSEcCtD
Maprotiline—Leukopenia—Pregabalin—epilepsy syndrome	2.28e-05	0.000246	CcSEcCtD
Maprotiline—Rash—Fosphenytoin—epilepsy syndrome	2.27e-05	0.000245	CcSEcCtD
Maprotiline—Dermatitis—Fosphenytoin—epilepsy syndrome	2.27e-05	0.000245	CcSEcCtD
Maprotiline—Nervousness—Gabapentin—epilepsy syndrome	2.26e-05	0.000245	CcSEcCtD
Maprotiline—Asthenia—Clonazepam—epilepsy syndrome	2.26e-05	0.000244	CcSEcCtD
Maprotiline—Headache—Fosphenytoin—epilepsy syndrome	2.25e-05	0.000243	CcSEcCtD
Maprotiline—Hepatitis—Topiramate—epilepsy syndrome	2.25e-05	0.000243	CcSEcCtD
Maprotiline—Nervous system disorder—Valproic Acid—epilepsy syndrome	2.25e-05	0.000243	CcSEcCtD
Maprotiline—Thrombocytopenia—Valproic Acid—epilepsy syndrome	2.25e-05	0.000243	CcSEcCtD
Maprotiline—Palpitations—Pregabalin—epilepsy syndrome	2.25e-05	0.000243	CcSEcCtD
Maprotiline—Asthenia—Phenytoin—epilepsy syndrome	2.25e-05	0.000243	CcSEcCtD
Maprotiline—Nausea—Midazolam—epilepsy syndrome	2.24e-05	0.000242	CcSEcCtD
Maprotiline—Hallucination—Topiramate—epilepsy syndrome	2.24e-05	0.000242	CcSEcCtD
Maprotiline—Hypoaesthesia—Topiramate—epilepsy syndrome	2.24e-05	0.000242	CcSEcCtD
Maprotiline—Tachycardia—Valproic Acid—epilepsy syndrome	2.24e-05	0.000242	CcSEcCtD
Maprotiline—Diarrhoea—Zonisamide—epilepsy syndrome	2.24e-05	0.000242	CcSEcCtD
Maprotiline—Loss of consciousness—Pregabalin—epilepsy syndrome	2.23e-05	0.000241	CcSEcCtD
Maprotiline—Asthenia—Oxcarbazepine—epilepsy syndrome	2.23e-05	0.000241	CcSEcCtD
Maprotiline—Pruritus—Clonazepam—epilepsy syndrome	2.23e-05	0.000241	CcSEcCtD
Maprotiline—Vomiting—Vigabatrin—epilepsy syndrome	2.23e-05	0.000241	CcSEcCtD
Maprotiline—Skin disorder—Valproic Acid—epilepsy syndrome	2.23e-05	0.000241	CcSEcCtD
Maprotiline—Urinary tract disorder—Topiramate—epilepsy syndrome	2.23e-05	0.00024	CcSEcCtD
Maprotiline—Hyperhidrosis—Valproic Acid—epilepsy syndrome	2.22e-05	0.00024	CcSEcCtD
Maprotiline—Pruritus—Phenytoin—epilepsy syndrome	2.22e-05	0.000239	CcSEcCtD
Maprotiline—Nausea—Levetiracetam—epilepsy syndrome	2.21e-05	0.000239	CcSEcCtD
Maprotiline—Rash—Vigabatrin—epilepsy syndrome	2.21e-05	0.000239	CcSEcCtD
Maprotiline—Dizziness—Felbamate—epilepsy syndrome	2.21e-05	0.000239	CcSEcCtD
Maprotiline—Dermatitis—Vigabatrin—epilepsy syndrome	2.21e-05	0.000239	CcSEcCtD
Maprotiline—Urethral disorder—Topiramate—epilepsy syndrome	2.21e-05	0.000239	CcSEcCtD
Maprotiline—Pruritus—Oxcarbazepine—epilepsy syndrome	2.2e-05	0.000238	CcSEcCtD
Maprotiline—Convulsion—Pregabalin—epilepsy syndrome	2.2e-05	0.000238	CcSEcCtD
Maprotiline—Vision blurred—Gabapentin—epilepsy syndrome	2.2e-05	0.000237	CcSEcCtD
Maprotiline—Headache—Vigabatrin—epilepsy syndrome	2.2e-05	0.000237	CcSEcCtD
Maprotiline—Hypertension—Pregabalin—epilepsy syndrome	2.2e-05	0.000237	CcSEcCtD
Maprotiline—Vomiting—Diazepam—epilepsy syndrome	2.2e-05	0.000237	CcSEcCtD
Maprotiline—Tremor—Gabapentin—epilepsy syndrome	2.18e-05	0.000236	CcSEcCtD
Maprotiline—Rash—Diazepam—epilepsy syndrome	2.18e-05	0.000235	CcSEcCtD
Maprotiline—Dermatitis—Diazepam—epilepsy syndrome	2.17e-05	0.000235	CcSEcCtD
Maprotiline—Dizziness—Zonisamide—epilepsy syndrome	2.16e-05	0.000234	CcSEcCtD
Maprotiline—Headache—Diazepam—epilepsy syndrome	2.16e-05	0.000234	CcSEcCtD
Maprotiline—Anxiety—Pregabalin—epilepsy syndrome	2.16e-05	0.000233	CcSEcCtD
Maprotiline—Diarrhoea—Clonazepam—epilepsy syndrome	2.16e-05	0.000233	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Pregabalin—epilepsy syndrome	2.15e-05	0.000232	CcSEcCtD
Maprotiline—Hypotension—Valproic Acid—epilepsy syndrome	2.15e-05	0.000232	CcSEcCtD
Maprotiline—Asthenia—Carbamazepine—epilepsy syndrome	2.14e-05	0.000232	CcSEcCtD
Maprotiline—Agitation—Gabapentin—epilepsy syndrome	2.14e-05	0.000231	CcSEcCtD
Maprotiline—Diarrhoea—Phenytoin—epilepsy syndrome	2.14e-05	0.000231	CcSEcCtD
Maprotiline—Nausea—Fosphenytoin—epilepsy syndrome	2.14e-05	0.000231	CcSEcCtD
Maprotiline—Diarrhoea—Oxcarbazepine—epilepsy syndrome	2.13e-05	0.00023	CcSEcCtD
Maprotiline—Erythema multiforme—Topiramate—epilepsy syndrome	2.13e-05	0.00023	CcSEcCtD
Maprotiline—Vomiting—Felbamate—epilepsy syndrome	2.12e-05	0.000229	CcSEcCtD
Maprotiline—Dry mouth—Pregabalin—epilepsy syndrome	2.12e-05	0.000229	CcSEcCtD
Maprotiline—Pruritus—Carbamazepine—epilepsy syndrome	2.11e-05	0.000228	CcSEcCtD
Maprotiline—Nortriptyline—CYP2D6—epilepsy syndrome	2.11e-05	0.0109	CrCbGaD
Maprotiline—Rash—Felbamate—epilepsy syndrome	2.11e-05	0.000227	CcSEcCtD
Maprotiline—Eye disorder—Topiramate—epilepsy syndrome	2.11e-05	0.000227	CcSEcCtD
Maprotiline—Dermatitis—Felbamate—epilepsy syndrome	2.11e-05	0.000227	CcSEcCtD
Maprotiline—Tinnitus—Topiramate—epilepsy syndrome	2.1e-05	0.000227	CcSEcCtD
Maprotiline—Imipramine—SLC6A4—epilepsy syndrome	2.1e-05	0.0108	CrCbGaD
Maprotiline—Headache—Felbamate—epilepsy syndrome	2.09e-05	0.000226	CcSEcCtD
Maprotiline—Confusional state—Pregabalin—epilepsy syndrome	2.09e-05	0.000226	CcSEcCtD
Maprotiline—Flushing—Topiramate—epilepsy syndrome	2.09e-05	0.000226	CcSEcCtD
Maprotiline—Cardiac disorder—Topiramate—epilepsy syndrome	2.09e-05	0.000226	CcSEcCtD
Maprotiline—Syncope—Gabapentin—epilepsy syndrome	2.09e-05	0.000226	CcSEcCtD
Maprotiline—Leukopenia—Gabapentin—epilepsy syndrome	2.09e-05	0.000225	CcSEcCtD
Maprotiline—Dizziness—Clonazepam—epilepsy syndrome	2.08e-05	0.000225	CcSEcCtD
Maprotiline—Nausea—Vigabatrin—epilepsy syndrome	2.08e-05	0.000225	CcSEcCtD
Maprotiline—Vomiting—Zonisamide—epilepsy syndrome	2.08e-05	0.000225	CcSEcCtD
Maprotiline—Insomnia—Valproic Acid—epilepsy syndrome	2.08e-05	0.000224	CcSEcCtD
Maprotiline—Oedema—Pregabalin—epilepsy syndrome	2.08e-05	0.000224	CcSEcCtD
Maprotiline—Asthenia—Lamotrigine—epilepsy syndrome	2.07e-05	0.000224	CcSEcCtD
Maprotiline—Dizziness—Phenytoin—epilepsy syndrome	2.07e-05	0.000224	CcSEcCtD
Maprotiline—Rash—Zonisamide—epilepsy syndrome	2.06e-05	0.000223	CcSEcCtD
Maprotiline—Infection—Pregabalin—epilepsy syndrome	2.06e-05	0.000223	CcSEcCtD
Maprotiline—Paraesthesia—Valproic Acid—epilepsy syndrome	2.06e-05	0.000223	CcSEcCtD
Maprotiline—Palpitations—Gabapentin—epilepsy syndrome	2.06e-05	0.000222	CcSEcCtD
Maprotiline—Dermatitis—Zonisamide—epilepsy syndrome	2.06e-05	0.000222	CcSEcCtD
Maprotiline—Dizziness—Oxcarbazepine—epilepsy syndrome	2.06e-05	0.000222	CcSEcCtD
Maprotiline—Nausea—Diazepam—epilepsy syndrome	2.05e-05	0.000221	CcSEcCtD
Maprotiline—Loss of consciousness—Gabapentin—epilepsy syndrome	2.05e-05	0.000221	CcSEcCtD
Maprotiline—Headache—Zonisamide—epilepsy syndrome	2.05e-05	0.000221	CcSEcCtD
Maprotiline—Diarrhoea—Carbamazepine—epilepsy syndrome	2.05e-05	0.000221	CcSEcCtD
Maprotiline—Angiopathy—Topiramate—epilepsy syndrome	2.04e-05	0.000221	CcSEcCtD
Maprotiline—Pruritus—Lamotrigine—epilepsy syndrome	2.04e-05	0.000221	CcSEcCtD
Maprotiline—Shock—Pregabalin—epilepsy syndrome	2.04e-05	0.00022	CcSEcCtD
Maprotiline—Somnolence—Valproic Acid—epilepsy syndrome	2.04e-05	0.00022	CcSEcCtD
Maprotiline—Nervous system disorder—Pregabalin—epilepsy syndrome	2.04e-05	0.00022	CcSEcCtD
Maprotiline—Thrombocytopenia—Pregabalin—epilepsy syndrome	2.03e-05	0.000219	CcSEcCtD
Maprotiline—Mediastinal disorder—Topiramate—epilepsy syndrome	2.03e-05	0.000219	CcSEcCtD
Maprotiline—Tachycardia—Pregabalin—epilepsy syndrome	2.03e-05	0.000219	CcSEcCtD
Maprotiline—Dyspepsia—Valproic Acid—epilepsy syndrome	2.02e-05	0.000218	CcSEcCtD
Maprotiline—Convulsion—Gabapentin—epilepsy syndrome	2.02e-05	0.000218	CcSEcCtD
Maprotiline—Skin disorder—Pregabalin—epilepsy syndrome	2.02e-05	0.000218	CcSEcCtD
Maprotiline—Hypertension—Gabapentin—epilepsy syndrome	2.01e-05	0.000217	CcSEcCtD
Maprotiline—Hyperhidrosis—Pregabalin—epilepsy syndrome	2.01e-05	0.000217	CcSEcCtD
Maprotiline—Vomiting—Clonazepam—epilepsy syndrome	2e-05	0.000216	CcSEcCtD
Maprotiline—Alopecia—Topiramate—epilepsy syndrome	1.99e-05	0.000215	CcSEcCtD
Maprotiline—Vomiting—Phenytoin—epilepsy syndrome	1.99e-05	0.000215	CcSEcCtD
Maprotiline—Imipramine—CYP2C19—epilepsy syndrome	1.99e-05	0.0103	CrCbGaD
Maprotiline—Rash—Clonazepam—epilepsy syndrome	1.99e-05	0.000215	CcSEcCtD
Maprotiline—Dermatitis—Clonazepam—epilepsy syndrome	1.99e-05	0.000214	CcSEcCtD
Maprotiline—Nausea—Felbamate—epilepsy syndrome	1.98e-05	0.000214	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Valproic Acid—epilepsy syndrome	1.98e-05	0.000214	CcSEcCtD
Maprotiline—Vomiting—Oxcarbazepine—epilepsy syndrome	1.98e-05	0.000214	CcSEcCtD
Maprotiline—Fatigue—Valproic Acid—epilepsy syndrome	1.98e-05	0.000214	CcSEcCtD
Maprotiline—Anxiety—Gabapentin—epilepsy syndrome	1.98e-05	0.000214	CcSEcCtD
Maprotiline—Dizziness—Carbamazepine—epilepsy syndrome	1.98e-05	0.000213	CcSEcCtD
Maprotiline—Diarrhoea—Lamotrigine—epilepsy syndrome	1.98e-05	0.000213	CcSEcCtD
Maprotiline—Headache—Clonazepam—epilepsy syndrome	1.97e-05	0.000213	CcSEcCtD
Maprotiline—Rash—Phenytoin—epilepsy syndrome	1.97e-05	0.000213	CcSEcCtD
Maprotiline—Dermatitis—Phenytoin—epilepsy syndrome	1.97e-05	0.000213	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Gabapentin—epilepsy syndrome	1.97e-05	0.000213	CcSEcCtD
Maprotiline—Rash—Oxcarbazepine—epilepsy syndrome	1.96e-05	0.000212	CcSEcCtD
Maprotiline—Constipation—Valproic Acid—epilepsy syndrome	1.96e-05	0.000212	CcSEcCtD
Maprotiline—Dermatitis—Oxcarbazepine—epilepsy syndrome	1.96e-05	0.000212	CcSEcCtD
Maprotiline—Headache—Phenytoin—epilepsy syndrome	1.96e-05	0.000212	CcSEcCtD
Maprotiline—Malnutrition—Topiramate—epilepsy syndrome	1.96e-05	0.000212	CcSEcCtD
Maprotiline—Headache—Oxcarbazepine—epilepsy syndrome	1.95e-05	0.000211	CcSEcCtD
Maprotiline—Nausea—Zonisamide—epilepsy syndrome	1.94e-05	0.00021	CcSEcCtD
Maprotiline—Dry mouth—Gabapentin—epilepsy syndrome	1.94e-05	0.00021	CcSEcCtD
Maprotiline—Hypotension—Pregabalin—epilepsy syndrome	1.94e-05	0.000209	CcSEcCtD
Maprotiline—Tension—Topiramate—epilepsy syndrome	1.93e-05	0.000208	CcSEcCtD
Maprotiline—Dysgeusia—Topiramate—epilepsy syndrome	1.92e-05	0.000207	CcSEcCtD
Maprotiline—Confusional state—Gabapentin—epilepsy syndrome	1.92e-05	0.000207	CcSEcCtD
Maprotiline—Dizziness—Lamotrigine—epilepsy syndrome	1.91e-05	0.000206	CcSEcCtD
Maprotiline—Nervousness—Topiramate—epilepsy syndrome	1.91e-05	0.000206	CcSEcCtD
Maprotiline—Oedema—Gabapentin—epilepsy syndrome	1.9e-05	0.000205	CcSEcCtD
Maprotiline—Desipramine—HTR2A—epilepsy syndrome	1.9e-05	0.00983	CrCbGaD
Maprotiline—Vomiting—Carbamazepine—epilepsy syndrome	1.9e-05	0.000205	CcSEcCtD
Maprotiline—Feeling abnormal—Valproic Acid—epilepsy syndrome	1.89e-05	0.000204	CcSEcCtD
Maprotiline—Infection—Gabapentin—epilepsy syndrome	1.89e-05	0.000204	CcSEcCtD
Maprotiline—Rash—Carbamazepine—epilepsy syndrome	1.88e-05	0.000203	CcSEcCtD
Maprotiline—Dermatitis—Carbamazepine—epilepsy syndrome	1.88e-05	0.000203	CcSEcCtD
Maprotiline—Gastrointestinal pain—Valproic Acid—epilepsy syndrome	1.88e-05	0.000203	CcSEcCtD
Maprotiline—Insomnia—Pregabalin—epilepsy syndrome	1.88e-05	0.000203	CcSEcCtD
Maprotiline—Nausea—Clonazepam—epilepsy syndrome	1.87e-05	0.000202	CcSEcCtD
Maprotiline—Headache—Carbamazepine—epilepsy syndrome	1.87e-05	0.000202	CcSEcCtD
Maprotiline—Shock—Gabapentin—epilepsy syndrome	1.87e-05	0.000202	CcSEcCtD
Maprotiline—Nervous system disorder—Gabapentin—epilepsy syndrome	1.87e-05	0.000201	CcSEcCtD
Maprotiline—Paraesthesia—Pregabalin—epilepsy syndrome	1.86e-05	0.000201	CcSEcCtD
Maprotiline—Thrombocytopenia—Gabapentin—epilepsy syndrome	1.86e-05	0.000201	CcSEcCtD
Maprotiline—Nausea—Phenytoin—epilepsy syndrome	1.86e-05	0.000201	CcSEcCtD
Maprotiline—Tachycardia—Gabapentin—epilepsy syndrome	1.86e-05	0.000201	CcSEcCtD
Maprotiline—Nausea—Oxcarbazepine—epilepsy syndrome	1.85e-05	0.0002	CcSEcCtD
Maprotiline—Vision blurred—Topiramate—epilepsy syndrome	1.85e-05	0.0002	CcSEcCtD
Maprotiline—Skin disorder—Gabapentin—epilepsy syndrome	1.85e-05	0.0002	CcSEcCtD
Maprotiline—Somnolence—Pregabalin—epilepsy syndrome	1.84e-05	0.000199	CcSEcCtD
Maprotiline—Hyperhidrosis—Gabapentin—epilepsy syndrome	1.84e-05	0.000199	CcSEcCtD
Maprotiline—Tremor—Topiramate—epilepsy syndrome	1.84e-05	0.000198	CcSEcCtD
Maprotiline—Vomiting—Lamotrigine—epilepsy syndrome	1.84e-05	0.000198	CcSEcCtD
Maprotiline—Urticaria—Valproic Acid—epilepsy syndrome	1.82e-05	0.000197	CcSEcCtD
Maprotiline—Rash—Lamotrigine—epilepsy syndrome	1.82e-05	0.000197	CcSEcCtD
Maprotiline—Dermatitis—Lamotrigine—epilepsy syndrome	1.82e-05	0.000196	CcSEcCtD
Maprotiline—Abdominal pain—Valproic Acid—epilepsy syndrome	1.81e-05	0.000196	CcSEcCtD
Maprotiline—Body temperature increased—Valproic Acid—epilepsy syndrome	1.81e-05	0.000196	CcSEcCtD
Maprotiline—Headache—Lamotrigine—epilepsy syndrome	1.81e-05	0.000195	CcSEcCtD
Maprotiline—Agitation—Topiramate—epilepsy syndrome	1.8e-05	0.000195	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Pregabalin—epilepsy syndrome	1.79e-05	0.000193	CcSEcCtD
Maprotiline—Fatigue—Pregabalin—epilepsy syndrome	1.79e-05	0.000193	CcSEcCtD
Maprotiline—Hypotension—Gabapentin—epilepsy syndrome	1.78e-05	0.000192	CcSEcCtD
Maprotiline—Nausea—Carbamazepine—epilepsy syndrome	1.78e-05	0.000192	CcSEcCtD
Maprotiline—Constipation—Pregabalin—epilepsy syndrome	1.77e-05	0.000192	CcSEcCtD
Maprotiline—Syncope—Topiramate—epilepsy syndrome	1.76e-05	0.00019	CcSEcCtD
Maprotiline—Leukopenia—Topiramate—epilepsy syndrome	1.76e-05	0.00019	CcSEcCtD
Maprotiline—Desipramine—CYP2D6—epilepsy syndrome	1.74e-05	0.00899	CrCbGaD
Maprotiline—Palpitations—Topiramate—epilepsy syndrome	1.73e-05	0.000187	CcSEcCtD
Maprotiline—Loss of consciousness—Topiramate—epilepsy syndrome	1.72e-05	0.000186	CcSEcCtD
Maprotiline—Insomnia—Gabapentin—epilepsy syndrome	1.72e-05	0.000186	CcSEcCtD
Maprotiline—Nausea—Lamotrigine—epilepsy syndrome	1.72e-05	0.000185	CcSEcCtD
Maprotiline—Feeling abnormal—Pregabalin—epilepsy syndrome	1.71e-05	0.000185	CcSEcCtD
Maprotiline—Paraesthesia—Gabapentin—epilepsy syndrome	1.71e-05	0.000184	CcSEcCtD
Maprotiline—Convulsion—Topiramate—epilepsy syndrome	1.7e-05	0.000184	CcSEcCtD
Maprotiline—Gastrointestinal pain—Pregabalin—epilepsy syndrome	1.7e-05	0.000183	CcSEcCtD
Maprotiline—Hypertension—Topiramate—epilepsy syndrome	1.69e-05	0.000183	CcSEcCtD
Maprotiline—Somnolence—Gabapentin—epilepsy syndrome	1.69e-05	0.000183	CcSEcCtD
Maprotiline—Dyspepsia—Gabapentin—epilepsy syndrome	1.68e-05	0.000181	CcSEcCtD
Maprotiline—Anxiety—Topiramate—epilepsy syndrome	1.66e-05	0.00018	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Topiramate—epilepsy syndrome	1.66e-05	0.000179	CcSEcCtD
Maprotiline—Urticaria—Pregabalin—epilepsy syndrome	1.65e-05	0.000178	CcSEcCtD
Maprotiline—Asthenia—Valproic Acid—epilepsy syndrome	1.65e-05	0.000178	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Gabapentin—epilepsy syndrome	1.64e-05	0.000177	CcSEcCtD
Maprotiline—Fatigue—Gabapentin—epilepsy syndrome	1.64e-05	0.000177	CcSEcCtD
Maprotiline—Abdominal pain—Pregabalin—epilepsy syndrome	1.64e-05	0.000177	CcSEcCtD
Maprotiline—Body temperature increased—Pregabalin—epilepsy syndrome	1.64e-05	0.000177	CcSEcCtD
Maprotiline—Dry mouth—Topiramate—epilepsy syndrome	1.63e-05	0.000176	CcSEcCtD
Maprotiline—Constipation—Gabapentin—epilepsy syndrome	1.63e-05	0.000176	CcSEcCtD
Maprotiline—Pruritus—Valproic Acid—epilepsy syndrome	1.62e-05	0.000175	CcSEcCtD
Maprotiline—Confusional state—Topiramate—epilepsy syndrome	1.61e-05	0.000174	CcSEcCtD
Maprotiline—Imipramine—HTR2A—epilepsy syndrome	1.61e-05	0.00833	CrCbGaD
Maprotiline—Oedema—Topiramate—epilepsy syndrome	1.6e-05	0.000173	CcSEcCtD
Maprotiline—Infection—Topiramate—epilepsy syndrome	1.59e-05	0.000172	CcSEcCtD
Maprotiline—Nortriptyline—ALB—epilepsy syndrome	1.58e-05	0.00817	CrCbGaD
Maprotiline—Shock—Topiramate—epilepsy syndrome	1.58e-05	0.00017	CcSEcCtD
Maprotiline—Diarrhoea—Valproic Acid—epilepsy syndrome	1.57e-05	0.00017	CcSEcCtD
Maprotiline—Nervous system disorder—Topiramate—epilepsy syndrome	1.57e-05	0.00017	CcSEcCtD
Maprotiline—Feeling abnormal—Gabapentin—epilepsy syndrome	1.57e-05	0.000169	CcSEcCtD
Maprotiline—Thrombocytopenia—Topiramate—epilepsy syndrome	1.57e-05	0.000169	CcSEcCtD
Maprotiline—Tachycardia—Topiramate—epilepsy syndrome	1.56e-05	0.000169	CcSEcCtD
Maprotiline—Gastrointestinal pain—Gabapentin—epilepsy syndrome	1.56e-05	0.000168	CcSEcCtD
Maprotiline—Skin disorder—Topiramate—epilepsy syndrome	1.56e-05	0.000168	CcSEcCtD
Maprotiline—Hyperhidrosis—Topiramate—epilepsy syndrome	1.55e-05	0.000167	CcSEcCtD
Maprotiline—Dizziness—Valproic Acid—epilepsy syndrome	1.52e-05	0.000164	CcSEcCtD
Maprotiline—Urticaria—Gabapentin—epilepsy syndrome	1.51e-05	0.000163	CcSEcCtD
Maprotiline—Body temperature increased—Gabapentin—epilepsy syndrome	1.5e-05	0.000162	CcSEcCtD
Maprotiline—Abdominal pain—Gabapentin—epilepsy syndrome	1.5e-05	0.000162	CcSEcCtD
Maprotiline—Hypotension—Topiramate—epilepsy syndrome	1.5e-05	0.000162	CcSEcCtD
Maprotiline—Asthenia—Pregabalin—epilepsy syndrome	1.49e-05	0.000161	CcSEcCtD
Maprotiline—Imipramine—CYP2D6—epilepsy syndrome	1.47e-05	0.00762	CrCbGaD
Maprotiline—Pruritus—Pregabalin—epilepsy syndrome	1.47e-05	0.000159	CcSEcCtD
Maprotiline—Vomiting—Valproic Acid—epilepsy syndrome	1.46e-05	0.000158	CcSEcCtD
Maprotiline—Insomnia—Topiramate—epilepsy syndrome	1.45e-05	0.000156	CcSEcCtD
Maprotiline—Rash—Valproic Acid—epilepsy syndrome	1.45e-05	0.000156	CcSEcCtD
Maprotiline—Dermatitis—Valproic Acid—epilepsy syndrome	1.45e-05	0.000156	CcSEcCtD
Maprotiline—Headache—Valproic Acid—epilepsy syndrome	1.44e-05	0.000155	CcSEcCtD
Maprotiline—Paraesthesia—Topiramate—epilepsy syndrome	1.44e-05	0.000155	CcSEcCtD
Maprotiline—Somnolence—Topiramate—epilepsy syndrome	1.42e-05	0.000154	CcSEcCtD
Maprotiline—Diarrhoea—Pregabalin—epilepsy syndrome	1.42e-05	0.000153	CcSEcCtD
Maprotiline—Dyspepsia—Topiramate—epilepsy syndrome	1.41e-05	0.000152	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Topiramate—epilepsy syndrome	1.38e-05	0.000149	CcSEcCtD
Maprotiline—Fatigue—Topiramate—epilepsy syndrome	1.38e-05	0.000149	CcSEcCtD
Maprotiline—Dizziness—Pregabalin—epilepsy syndrome	1.37e-05	0.000148	CcSEcCtD
Maprotiline—Constipation—Topiramate—epilepsy syndrome	1.37e-05	0.000148	CcSEcCtD
Maprotiline—Asthenia—Gabapentin—epilepsy syndrome	1.37e-05	0.000147	CcSEcCtD
Maprotiline—Nausea—Valproic Acid—epilepsy syndrome	1.36e-05	0.000147	CcSEcCtD
Maprotiline—Pruritus—Gabapentin—epilepsy syndrome	1.35e-05	0.000145	CcSEcCtD
Maprotiline—Vomiting—Pregabalin—epilepsy syndrome	1.32e-05	0.000142	CcSEcCtD
Maprotiline—Feeling abnormal—Topiramate—epilepsy syndrome	1.32e-05	0.000142	CcSEcCtD
Maprotiline—Gastrointestinal pain—Topiramate—epilepsy syndrome	1.31e-05	0.000141	CcSEcCtD
Maprotiline—Rash—Pregabalin—epilepsy syndrome	1.31e-05	0.000141	CcSEcCtD
Maprotiline—Dermatitis—Pregabalin—epilepsy syndrome	1.31e-05	0.000141	CcSEcCtD
Maprotiline—Diarrhoea—Gabapentin—epilepsy syndrome	1.3e-05	0.000141	CcSEcCtD
Maprotiline—Headache—Pregabalin—epilepsy syndrome	1.3e-05	0.00014	CcSEcCtD
Maprotiline—Urticaria—Topiramate—epilepsy syndrome	1.27e-05	0.000137	CcSEcCtD
Maprotiline—Abdominal pain—Topiramate—epilepsy syndrome	1.27e-05	0.000137	CcSEcCtD
Maprotiline—Body temperature increased—Topiramate—epilepsy syndrome	1.27e-05	0.000137	CcSEcCtD
Maprotiline—Dizziness—Gabapentin—epilepsy syndrome	1.26e-05	0.000136	CcSEcCtD
Maprotiline—Desipramine—ABCB1—epilepsy syndrome	1.24e-05	0.00642	CrCbGaD
Maprotiline—Nausea—Pregabalin—epilepsy syndrome	1.23e-05	0.000133	CcSEcCtD
Maprotiline—Vomiting—Gabapentin—epilepsy syndrome	1.21e-05	0.000131	CcSEcCtD
Maprotiline—Rash—Gabapentin—epilepsy syndrome	1.2e-05	0.00013	CcSEcCtD
Maprotiline—Dermatitis—Gabapentin—epilepsy syndrome	1.2e-05	0.000129	CcSEcCtD
Maprotiline—Headache—Gabapentin—epilepsy syndrome	1.19e-05	0.000129	CcSEcCtD
Maprotiline—Asthenia—Topiramate—epilepsy syndrome	1.15e-05	0.000124	CcSEcCtD
Maprotiline—Pruritus—Topiramate—epilepsy syndrome	1.13e-05	0.000122	CcSEcCtD
Maprotiline—Nausea—Gabapentin—epilepsy syndrome	1.13e-05	0.000122	CcSEcCtD
Maprotiline—Diarrhoea—Topiramate—epilepsy syndrome	1.1e-05	0.000118	CcSEcCtD
Maprotiline—Dizziness—Topiramate—epilepsy syndrome	1.06e-05	0.000114	CcSEcCtD
Maprotiline—Imipramine—ABCB1—epilepsy syndrome	1.05e-05	0.00544	CrCbGaD
Maprotiline—Vomiting—Topiramate—epilepsy syndrome	1.02e-05	0.00011	CcSEcCtD
Maprotiline—Rash—Topiramate—epilepsy syndrome	1.01e-05	0.000109	CcSEcCtD
Maprotiline—Dermatitis—Topiramate—epilepsy syndrome	1.01e-05	0.000109	CcSEcCtD
Maprotiline—Headache—Topiramate—epilepsy syndrome	1e-05	0.000108	CcSEcCtD
Maprotiline—Nausea—Topiramate—epilepsy syndrome	9.51e-06	0.000103	CcSEcCtD
Maprotiline—HTR2A—Signaling Pathways—MEF2C—epilepsy syndrome	1.14e-06	2.23e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—FYN—epilepsy syndrome	1.14e-06	2.23e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—H2AFX—epilepsy syndrome	1.14e-06	2.23e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—PLCB1—epilepsy syndrome	1.13e-06	2.23e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—MEF2C—epilepsy syndrome	1.13e-06	2.23e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—FYN—epilepsy syndrome	1.13e-06	2.22e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—BCHE—epilepsy syndrome	1.13e-06	2.22e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—H2AFX—epilepsy syndrome	1.13e-06	2.22e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—TSC2—epilepsy syndrome	1.13e-06	2.22e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—MEF2C—epilepsy syndrome	1.13e-06	2.22e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—TH—epilepsy syndrome	1.13e-06	2.22e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—AGT—epilepsy syndrome	1.13e-06	2.22e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—H2AFX—epilepsy syndrome	1.13e-06	2.22e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—CYP2C19—epilepsy syndrome	1.13e-06	2.22e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—MEF2C—epilepsy syndrome	1.13e-06	2.21e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—FYN—epilepsy syndrome	1.12e-06	2.2e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—CYP11A1—epilepsy syndrome	1.12e-06	2.2e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—H2AFX—epilepsy syndrome	1.12e-06	2.19e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—YWHAZ—epilepsy syndrome	1.12e-06	2.19e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—MEF2C—epilepsy syndrome	1.12e-06	2.19e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—POMC—epilepsy syndrome	1.11e-06	2.19e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—APOE—epilepsy syndrome	1.11e-06	2.17e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—NGF—epilepsy syndrome	1.1e-06	2.17e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—YWHAZ—epilepsy syndrome	1.1e-06	2.16e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—YWHAZ—epilepsy syndrome	1.1e-06	2.15e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—YWHAZ—epilepsy syndrome	1.09e-06	2.14e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—YWHAZ—epilepsy syndrome	1.09e-06	2.14e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—NGF—epilepsy syndrome	1.09e-06	2.13e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—KDR—epilepsy syndrome	1.08e-06	2.13e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—NGF—epilepsy syndrome	1.08e-06	2.13e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—SLC2A1—epilepsy syndrome	1.08e-06	2.12e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—NGF—epilepsy syndrome	1.08e-06	2.12e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—YWHAZ—epilepsy syndrome	1.08e-06	2.12e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—FGF2—epilepsy syndrome	1.08e-06	2.11e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—NGF—epilepsy syndrome	1.08e-06	2.11e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CCR5—epilepsy syndrome	1.07e-06	2.11e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—PLCB1—epilepsy syndrome	1.07e-06	2.1e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—NGF—epilepsy syndrome	1.07e-06	2.09e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—TH—epilepsy syndrome	1.07e-06	2.09e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—RELA—epilepsy syndrome	1.06e-06	2.08e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CCR5—epilepsy syndrome	1.06e-06	2.07e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CCR5—epilepsy syndrome	1.05e-06	2.07e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CCR5—epilepsy syndrome	1.05e-06	2.06e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—HTR2A—epilepsy syndrome	1.05e-06	2.06e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CCR5—epilepsy syndrome	1.05e-06	2.06e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—PRKCB—epilepsy syndrome	1.04e-06	2.05e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—IL6ST—epilepsy syndrome	1.04e-06	2.04e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—MTOR—epilepsy syndrome	1.04e-06	2.04e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CCR5—epilepsy syndrome	1.04e-06	2.04e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—HTR2A—epilepsy syndrome	1.03e-06	2.02e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—FGF2—epilepsy syndrome	1.03e-06	2.02e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—HTR2A—epilepsy syndrome	1.03e-06	2.02e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—HTR2A—epilepsy syndrome	1.03e-06	2.01e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—ALB—epilepsy syndrome	1.02e-06	1.99e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—HTR2A—epilepsy syndrome	1.02e-06	1.99e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—CYP2D6—epilepsy syndrome	1.01e-06	1.99e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—RELA—epilepsy syndrome	1e-06	1.96e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—TSC2—epilepsy syndrome	9.98e-07	1.96e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—AGT—epilepsy syndrome	9.97e-07	1.96e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—TSC2—epilepsy syndrome	9.82e-07	1.93e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—AGT—epilepsy syndrome	9.81e-07	1.93e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—MTOR—epilepsy syndrome	9.81e-07	1.92e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—TSC2—epilepsy syndrome	9.8e-07	1.92e-05	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—POMC—epilepsy syndrome	9.79e-07	1.92e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—AGT—epilepsy syndrome	9.79e-07	1.92e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—TSC2—epilepsy syndrome	9.77e-07	1.92e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—APOE—epilepsy syndrome	9.77e-07	1.92e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—AGT—epilepsy syndrome	9.76e-07	1.92e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—TSC2—epilepsy syndrome	9.74e-07	1.91e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—AGT—epilepsy syndrome	9.73e-07	1.91e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—TSC2—epilepsy syndrome	9.64e-07	1.89e-05	CbGpPWpGaD
Maprotiline—HTR7—GPCR downstream signaling—AKT1—epilepsy syndrome	9.64e-07	1.89e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—ADRA2A—epilepsy syndrome	9.64e-07	1.89e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—AGT—epilepsy syndrome	9.63e-07	1.89e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—APOE—epilepsy syndrome	9.61e-07	1.89e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—BCHE—epilepsy syndrome	9.6e-07	1.88e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—APOE—epilepsy syndrome	9.59e-07	1.88e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—RELA—epilepsy syndrome	9.57e-07	1.88e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—KDR—epilepsy syndrome	9.57e-07	1.88e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—APOE—epilepsy syndrome	9.56e-07	1.88e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—CASP3—epilepsy syndrome	9.55e-07	1.87e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—APOE—epilepsy syndrome	9.53e-07	1.87e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—POMC—epilepsy syndrome	9.51e-07	1.87e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—APOE—epilepsy syndrome	9.44e-07	1.85e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—HMOX1—epilepsy syndrome	9.43e-07	1.85e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—KDR—epilepsy syndrome	9.42e-07	1.85e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—KDR—epilepsy syndrome	9.4e-07	1.84e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—MTOR—epilepsy syndrome	9.39e-07	1.84e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—KDR—epilepsy syndrome	9.37e-07	1.84e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—KDR—epilepsy syndrome	9.34e-07	1.83e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—CAT—epilepsy syndrome	9.31e-07	1.83e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—CCL2—epilepsy syndrome	9.3e-07	1.83e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—JUN—epilepsy syndrome	9.28e-07	1.82e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—KDR—epilepsy syndrome	9.25e-07	1.81e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—PRKCB—epilepsy syndrome	9.21e-07	1.81e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—IL6ST—epilepsy syndrome	9.18e-07	1.8e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—SLC2A1—epilepsy syndrome	9.15e-07	1.8e-05	CbGpPWpGaD
Maprotiline—CHRM4—GPCR downstream signaling—AKT1—epilepsy syndrome	9.1e-07	1.79e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—PRKCB—epilepsy syndrome	9.06e-07	1.78e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—PLCB1—epilepsy syndrome	9.05e-07	1.78e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—PRKCB—epilepsy syndrome	9.04e-07	1.78e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—IL6ST—epilepsy syndrome	9.03e-07	1.77e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—MMP9—epilepsy syndrome	9.02e-07	1.77e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—TH—epilepsy syndrome	9.02e-07	1.77e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—CASP3—epilepsy syndrome	9.02e-07	1.77e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—PRKCB—epilepsy syndrome	9.02e-07	1.77e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—IL6ST—epilepsy syndrome	9.01e-07	1.77e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—PRKCB—epilepsy syndrome	8.99e-07	1.76e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—IL6ST—epilepsy syndrome	8.98e-07	1.76e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—IL6ST—epilepsy syndrome	8.95e-07	1.76e-05	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—ALB—epilepsy syndrome	8.93e-07	1.75e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—PRKCB—epilepsy syndrome	8.9e-07	1.75e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—HMOX1—epilepsy syndrome	8.89e-07	1.74e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—epilepsy syndrome	8.88e-07	1.74e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—IL6ST—epilepsy syndrome	8.86e-07	1.74e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—CAT—epilepsy syndrome	8.77e-07	1.72e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—JUN—epilepsy syndrome	8.76e-07	1.72e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling by GPCR—AKT1—epilepsy syndrome	8.75e-07	1.72e-05	CbGpPWpGaD
Maprotiline—CHRM5—GPCR downstream signaling—AKT1—epilepsy syndrome	8.72e-07	1.71e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—CASP3—epilepsy syndrome	8.64e-07	1.7e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—ABCB1—epilepsy syndrome	8.53e-07	1.67e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—MMP9—epilepsy syndrome	8.52e-07	1.67e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—GPX1—epilepsy syndrome	8.42e-07	1.65e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—FGF2—epilepsy syndrome	8.41e-07	1.65e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—POMC—epilepsy syndrome	8.39e-07	1.65e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—JUN—epilepsy syndrome	8.39e-07	1.65e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—SRC—epilepsy syndrome	8.32e-07	1.63e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling by GPCR—AKT1—epilepsy syndrome	8.27e-07	1.62e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—POMC—epilepsy syndrome	8.26e-07	1.62e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—POMC—epilepsy syndrome	8.24e-07	1.62e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—POMC—epilepsy syndrome	8.21e-07	1.61e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CCL2—epilepsy syndrome	8.21e-07	1.61e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—POMC—epilepsy syndrome	8.19e-07	1.61e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—MMP9—epilepsy syndrome	8.16e-07	1.6e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—POMC—epilepsy syndrome	8.11e-07	1.59e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—VEGFA—epilepsy syndrome	8.1e-07	1.59e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CCL2—epilepsy syndrome	8.08e-07	1.59e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CCL2—epilepsy syndrome	8.06e-07	1.58e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CCL2—epilepsy syndrome	8.04e-07	1.58e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CCL2—epilepsy syndrome	8.01e-07	1.57e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CCL2—epilepsy syndrome	7.93e-07	1.56e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—GPX1—epilepsy syndrome	7.93e-07	1.56e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling by GPCR—AKT1—epilepsy syndrome	7.92e-07	1.55e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—SRC—epilepsy syndrome	7.86e-07	1.54e-05	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—PTGS2—epilepsy syndrome	7.81e-07	1.53e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—RELA—epilepsy syndrome	7.81e-07	1.53e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—MTOR—epilepsy syndrome	7.65e-07	1.5e-05	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—VEGFA—epilepsy syndrome	7.65e-07	1.5e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—HMOX1—epilepsy syndrome	7.53e-07	1.48e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—SRC—epilepsy syndrome	7.52e-07	1.48e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—CAT—epilepsy syndrome	7.43e-07	1.46e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—FGF2—epilepsy syndrome	7.42e-07	1.46e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—AGT—epilepsy syndrome	7.38e-07	1.45e-05	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—VEGFA—epilepsy syndrome	7.33e-07	1.44e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—FGF2—epilepsy syndrome	7.3e-07	1.43e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—FGF2—epilepsy syndrome	7.29e-07	1.43e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—FGF2—epilepsy syndrome	7.26e-07	1.43e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—FGF2—epilepsy syndrome	7.24e-07	1.42e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—APOE—epilepsy syndrome	7.23e-07	1.42e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—ABCB1—epilepsy syndrome	7.23e-07	1.42e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—FGF2—epilepsy syndrome	7.17e-07	1.41e-05	CbGpPWpGaD
Maprotiline—HTR2C—GPCR downstream signaling—AKT1—epilepsy syndrome	7.11e-07	1.39e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—CASP3—epilepsy syndrome	7.04e-07	1.38e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—AGT—epilepsy syndrome	6.96e-07	1.37e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—RELA—epilepsy syndrome	6.89e-07	1.35e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—JUN—epilepsy syndrome	6.84e-07	1.34e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—APOE—epilepsy syndrome	6.81e-07	1.34e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—RELA—epilepsy syndrome	6.78e-07	1.33e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—RELA—epilepsy syndrome	6.76e-07	1.33e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—MTOR—epilepsy syndrome	6.76e-07	1.33e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—RELA—epilepsy syndrome	6.74e-07	1.32e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—RELA—epilepsy syndrome	6.72e-07	1.32e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—GPX1—epilepsy syndrome	6.72e-07	1.32e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—RELA—epilepsy syndrome	6.66e-07	1.31e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—MMP9—epilepsy syndrome	6.65e-07	1.31e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—MTOR—epilepsy syndrome	6.65e-07	1.3e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—MTOR—epilepsy syndrome	6.63e-07	1.3e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—MTOR—epilepsy syndrome	6.61e-07	1.3e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—MTOR—epilepsy syndrome	6.59e-07	1.29e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—MTOR—epilepsy syndrome	6.53e-07	1.28e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling by GPCR—AKT1—epilepsy syndrome	6.45e-07	1.27e-05	CbGpPWpGaD
Maprotiline—DRD2—GPCR downstream signaling—AKT1—epilepsy syndrome	6.27e-07	1.23e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—CASP3—epilepsy syndrome	6.21e-07	1.22e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—POMC—epilepsy syndrome	6.21e-07	1.22e-05	CbGpPWpGaD
Maprotiline—HTR2A—GPCR downstream signaling—AKT1—epilepsy syndrome	6.17e-07	1.21e-05	CbGpPWpGaD
Maprotiline—HRH1—GPCR downstream signaling—AKT1—epilepsy syndrome	6.16e-07	1.21e-05	CbGpPWpGaD
Maprotiline—CHRM1—GPCR downstream signaling—AKT1—epilepsy syndrome	6.14e-07	1.2e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—SRC—epilepsy syndrome	6.13e-07	1.2e-05	CbGpPWpGaD
Maprotiline—CHRM3—GPCR downstream signaling—AKT1—epilepsy syndrome	6.12e-07	1.2e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—CASP3—epilepsy syndrome	6.11e-07	1.2e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—CASP3—epilepsy syndrome	6.1e-07	1.2e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—CASP3—epilepsy syndrome	6.08e-07	1.19e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—CASP3—epilepsy syndrome	6.06e-07	1.19e-05	CbGpPWpGaD
Maprotiline—CHRM2—GPCR downstream signaling—AKT1—epilepsy syndrome	6.06e-07	1.19e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—JUN—epilepsy syndrome	6.04e-07	1.18e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—CASP3—epilepsy syndrome	6e-07	1.18e-05	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—VEGFA—epilepsy syndrome	5.97e-07	1.17e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—JUN—epilepsy syndrome	5.94e-07	1.17e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—JUN—epilepsy syndrome	5.93e-07	1.16e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—JUN—epilepsy syndrome	5.91e-07	1.16e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—AGT—epilepsy syndrome	5.89e-07	1.16e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—JUN—epilepsy syndrome	5.89e-07	1.16e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—MMP9—epilepsy syndrome	5.87e-07	1.15e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—POMC—epilepsy syndrome	5.85e-07	1.15e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—JUN—epilepsy syndrome	5.83e-07	1.14e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—MMP9—epilepsy syndrome	5.78e-07	1.13e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—APOE—epilepsy syndrome	5.77e-07	1.13e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—MMP9—epilepsy syndrome	5.76e-07	1.13e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—MMP9—epilepsy syndrome	5.75e-07	1.13e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—MMP9—epilepsy syndrome	5.73e-07	1.12e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling by GPCR—AKT1—epilepsy syndrome	5.69e-07	1.12e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—MMP9—epilepsy syndrome	5.67e-07	1.11e-05	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—ALB—epilepsy syndrome	5.66e-07	1.11e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling by GPCR—AKT1—epilepsy syndrome	5.6e-07	1.1e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling by GPCR—AKT1—epilepsy syndrome	5.59e-07	1.1e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling by GPCR—AKT1—epilepsy syndrome	5.57e-07	1.09e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling by GPCR—AKT1—epilepsy syndrome	5.56e-07	1.09e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling by GPCR—AKT1—epilepsy syndrome	5.5e-07	1.08e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—SRC—epilepsy syndrome	5.41e-07	1.06e-05	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—ALB—epilepsy syndrome	5.34e-07	1.05e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—SRC—epilepsy syndrome	5.33e-07	1.05e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—SRC—epilepsy syndrome	5.32e-07	1.04e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—SRC—epilepsy syndrome	5.3e-07	1.04e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—SRC—epilepsy syndrome	5.28e-07	1.04e-05	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—VEGFA—epilepsy syndrome	5.27e-07	1.03e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—SRC—epilepsy syndrome	5.23e-07	1.03e-05	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—VEGFA—epilepsy syndrome	5.19e-07	1.02e-05	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—VEGFA—epilepsy syndrome	5.18e-07	1.02e-05	CbGpPWpGaD
Maprotiline—HTR7—Signaling Pathways—AKT1—epilepsy syndrome	5.17e-07	1.01e-05	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—VEGFA—epilepsy syndrome	5.16e-07	1.01e-05	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—VEGFA—epilepsy syndrome	5.14e-07	1.01e-05	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—VEGFA—epilepsy syndrome	5.09e-07	1e-05	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—POMC—epilepsy syndrome	4.96e-07	9.73e-06	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—PTGS2—epilepsy syndrome	4.96e-07	9.73e-06	CbGpPWpGaD
Maprotiline—CHRM4—Signaling Pathways—AKT1—epilepsy syndrome	4.88e-07	9.58e-06	CbGpPWpGaD
Maprotiline—CHRM5—Signaling Pathways—AKT1—epilepsy syndrome	4.68e-07	9.18e-06	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—PTGS2—epilepsy syndrome	4.67e-07	9.16e-06	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—ALB—epilepsy syndrome	4.52e-07	8.87e-06	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—PTGS2—epilepsy syndrome	3.96e-07	7.76e-06	CbGpPWpGaD
Maprotiline—CHRM3—Metabolism—AKT1—epilepsy syndrome	3.92e-07	7.7e-06	CbGpPWpGaD
Maprotiline—HTR2C—Signaling Pathways—AKT1—epilepsy syndrome	3.81e-07	7.48e-06	CbGpPWpGaD
Maprotiline—DRD2—Signaling Pathways—AKT1—epilepsy syndrome	3.36e-07	6.6e-06	CbGpPWpGaD
Maprotiline—HTR2A—Signaling Pathways—AKT1—epilepsy syndrome	3.31e-07	6.5e-06	CbGpPWpGaD
Maprotiline—HRH1—Signaling Pathways—AKT1—epilepsy syndrome	3.3e-07	6.48e-06	CbGpPWpGaD
Maprotiline—CHRM1—Signaling Pathways—AKT1—epilepsy syndrome	3.29e-07	6.46e-06	CbGpPWpGaD
Maprotiline—CHRM3—Signaling Pathways—AKT1—epilepsy syndrome	3.28e-07	6.44e-06	CbGpPWpGaD
Maprotiline—CHRM2—Signaling Pathways—AKT1—epilepsy syndrome	3.25e-07	6.38e-06	CbGpPWpGaD
Maprotiline—ABCB1—Metabolism—AKT1—epilepsy syndrome	2.49e-07	4.89e-06	CbGpPWpGaD
Maprotiline—CYP2D6—Metabolism—AKT1—epilepsy syndrome	2.35e-07	4.61e-06	CbGpPWpGaD
Maprotiline—CYP1A2—Metabolism—AKT1—epilepsy syndrome	1.99e-07	3.9e-06	CbGpPWpGaD
